Search research articles
Contact Us
Filters
Showing results (771-780 of 1,342) with videos related to
Page
of 135
Sort By:
Neurology
|
December 13, 2006
New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke
M Rodríguez-Yáñez, M Castellanos, M Blanco, et al.
Thrombosis and Haemostasis
|
July 13, 2013
The perioperative management of new direct oral anticoagulants: a question without answers
R Ferrandis, J Castillo, J de Andrés, et al.
The American Journal of Cardiology
|
November 1, 1992
Predictors, mechanisms and outcome of severe mitral regurgitation complicating percutaneous mitral valvotomy with the Inoue balloon
R Hernandez, C Macaya, C Bañuelos, et al.
Neurobiology of Disease
|
September 22, 2007
Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke
O Hurtado, J M Pradillo, D Fernández-López, et al.
Neurology
|
October 31, 2008
High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke
M Castellanos, T Sobrino, S Pedraza, et al.
Enfermeria Intensiva
|
October 14, 2020
Discharge survival of patients undergoing ECMO therapy after ECPR in a third level hospital
J Castillo García, J C Sánchez Salado, M Gual Santandreu, et al.
British Journal of Haematology
|
January 10, 2023
Dose reductions in patients with Waldenström macroglobulinaemia treated with ibrutinib
Shayna Sarosiek, Joshua N Gustine, Catherine A Flynn, et al.
Frontiers in Physiology
|
May 21, 2019
Changes in Physical Fitness After 12 Weeks of Structured Concurrent Exercise Training, High Intensity Interval Training, or Whole-Body Electromyostimulation Training in Sedentary Middle-Aged Adults: A Randomized Controlled Trial
Francisco J Amaro-Gahete, Alejandro De-la-O, Lucas Jurado-Fasoli, et al.
American Journal of Hematology
|
December 28, 2017
Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM rebound
Joshua N Gustine, Kirsten Meid, Toni Dubeau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2018
Prospective Clinical Trial of Ixazomib, Dexamethasone, and Rituximab as Primary Therapy in Waldenström Macroglobulinemia
Jorge J Castillo, Kirsten Meid, Joshua N Gustine, et al.
Page
of 135
Search research articles
Search
Showing results (771-780 of 1,342) with videos related to
Sort By:
Page
of 135
Neurology
|
December 13, 2006
New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke
M Rodríguez-Yáñez, M Castellanos, M Blanco, et al.
Thrombosis and Haemostasis
|
July 13, 2013
The perioperative management of new direct oral anticoagulants: a question without answers
R Ferrandis, J Castillo, J de Andrés, et al.
The American Journal of Cardiology
|
November 1, 1992
Predictors, mechanisms and outcome of severe mitral regurgitation complicating percutaneous mitral valvotomy with the Inoue balloon
R Hernandez, C Macaya, C Bañuelos, et al.
Neurobiology of Disease
|
September 22, 2007
Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke
O Hurtado, J M Pradillo, D Fernández-López, et al.
Neurology
|
October 31, 2008
High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke
M Castellanos, T Sobrino, S Pedraza, et al.
Enfermeria Intensiva
|
October 14, 2020
Discharge survival of patients undergoing ECMO therapy after ECPR in a third level hospital
J Castillo García, J C Sánchez Salado, M Gual Santandreu, et al.
British Journal of Haematology
|
January 10, 2023
Dose reductions in patients with Waldenström macroglobulinaemia treated with ibrutinib
Shayna Sarosiek, Joshua N Gustine, Catherine A Flynn, et al.
Frontiers in Physiology
|
May 21, 2019
Changes in Physical Fitness After 12 Weeks of Structured Concurrent Exercise Training, High Intensity Interval Training, or Whole-Body Electromyostimulation Training in Sedentary Middle-Aged Adults: A Randomized Controlled Trial
Francisco J Amaro-Gahete, Alejandro De-la-O, Lucas Jurado-Fasoli, et al.
American Journal of Hematology
|
December 28, 2017
Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM rebound
Joshua N Gustine, Kirsten Meid, Toni Dubeau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2018
Prospective Clinical Trial of Ixazomib, Dexamethasone, and Rituximab as Primary Therapy in Waldenström Macroglobulinemia
Jorge J Castillo, Kirsten Meid, Joshua N Gustine, et al.
Page
of 135